Bacstitch DNA Inc.
Los Altos, CA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1027 Ray Ave, Los Altos, CA 94022, USA
- Website
- bacstitchdna.com
- Founded
- 2021
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
About the company
Bacstitch DNA Inc., a for-profit biotechnology company based in Los Altos, California, operates as a recipient of federal research grants from the National Institutes of Health's National Human Genome Research Institute (NHGRI), focused on developing in vivo DNA assembly platforms for synthetic biology applications.
Bacstitch DNA has received three NHGRI Project Grants (CFDA 93.172, Human Genome Research program) totaling $15.7 million in combined obligated dollars across a three-year award window from May 2022 through September 2026. The company's entire recent federal footprint consists of prime recipient grants; no contract awards or subcontract relationships appear in the source data. Work is performed at Bacstitch DNA's San Carlos, California facility.
The company's capability portfolio centers on high-throughput, low-cost in vivo DNA assembly methods using bacterial conjugation, in vivo DNA cutting, and homologous recombination. Its core technology addresses limitations in existing methods such as Gibson assembly and Golden Gate assembly, which perform poorly on longer and complex DNA sequences exceeding 7 kilobases. Representative grant work includes a $1,077,022 award (September 1, 2026, through August 31, 2028) to develop and optimize a hierarchical in vivo DNA assembly platform for constructing long DNA sequences exceeding 80 kilobases by transitioning from sequential to hierarchical assembly workflows and integrating orthogonal bacterial conjugation systems; a $2.1 million award (July 10, 2023, through December 31, 2025) for multiplexed in vivo assembly of long and complex DNA using barcoded bacterial arrays for high-throughput sequence validation; and a prior $1.2 million award (May 10, 2022, through August 31, 2025) for multiplexed in vivo DNA assembly development. These grants target applications in biosynthetic pathway engineering, synthetic chromosome design, and combinatorial genetic library optimization.
Customer concentration is complete: 100% of awards fund NHGRI programs. One award (potential value $1.2 million, ultimate completion August 31, 2025) faces recompete in the next twenty-four months.
Quick answers
Is Bacstitch DNA Inc. registered in SAM.gov?
Yes. Bacstitch DNA Inc.'s SAM.gov registration is active through November 21, 2026.
What is Bacstitch DNA Inc.'s CAGE code?
Bacstitch DNA Inc.'s CAGE code is 170D8, and its Unique Entity ID (UEI) is K6ZEC3LCEKE1.
What is Bacstitch DNA Inc.'s most recent federal award?
Bacstitch DNA Inc.'s most recent federal grant award is Hierarchical in vivo assembly for rapid and high-throughput construction of long DNA sequences (R44HG014736), from National Human Genome Research Institute (NIH), on September 1, 2026.
On GovTribe
See Bacstitch DNA Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors